The goal with the research is to develop strategies for the treatment of disseminated cancer using alpha-particle emitters as the leading actor.
The Targeted Alpha Therapy Group (TAT Group) started its research activities along with the publication of 2 articles in 1998. Since then, 60 articles have been published/accepted in peer-reviewed scientific journals and 8 PhD thesis have been presented, all relating to the work within the group.
Staff working in or in close collaboration with the TAT Group has different backgrounds varying from nuclear or radiation physics, chemistry, medicine and molecular or microbiology.
The cooperation within the group is characterized by a frequent and continuous exchange of ideas and planning of experiments, among the whole or parts of the group.